Propionic Acid

Propionic Acid

SCHEMBL4155190

CCC(=O)O.CS(=O)(=O)c1ccc(-c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)cc1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 12/20 0.40
KDM4E B2RXH2 2/20 0.40
RXFP1 Q9HBX9 1/20 0.39
WEE1 P30291 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
PARP1 P09874 1/20 0.36
JAK2 O60674 1/20 0.36
BRD4 O60885 1/20 0.35
GRIK1 P39086 1/20 0.35
GRIK2 Q13002 1/20 0.35
GRIK3 Q13003 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4155344 0.92 FASN (0.42) PTGS2RXFP1GRIN2DGRIN3BGRIN1
Propionic Acid SCHEMBL4157983 0.88 BRD4 (0.37) PTGS2WEE1JAK2BRD4
Propionic Acid SCHEMBL4153840 0.87 PIM1 (0.44) KDM4EGRIN2DGRIN3BALDH1A1GRIN1
Butyric Acid SCHEMBL4153848 0.86 FASN (0.41) PTGS2RXFP1GRIN2DGRIN3BGRIN1
Propionic Acid SCHEMBL4162600 0.85 PARP1 (0.38) PTGS2KDM4EGRIN2DGRIN3BALDH1A1
Propionic Acid SCHEMBL4155193 0.85 RXFP1 (0.41) KDM4ERXFP1GRIN2DGRIN3BALDH1A1
Propionic Acid SCHEMBL4162945 0.84 KDM4E (0.47) KDM4ERXFP1GRIN2DGRIN3BALDH1A1
Propionic Acid SCHEMBL4160151 0.84 PTGS2 (0.48) PTGS2
Propionic Acid SCHEMBL4162918 0.84 BRAF (0.46) KDM4ERXFP1
Propionic Acid SCHEMBL4167721 0.83 PRKAG1 (0.46) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PTGS2 312/4885KDM4E 1970/4885RXFP1 3999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.